相关实验视频
Updated: Feb 5, 2026

A Real-world What-Where-When Memory Test
Published on: May 16, 2017
DOT1L通过PRC1.1对抗提供了转录记忆
Daniel Neville1, Daniel T Ferguson1, Emily B Heikamp2
1Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
DOT1L和Menin抑制剂通过改变Polycomb抑制复合体1.1 (PRC1.1) 活性来影响白血病. 这项研究揭示了DOT1L.
科学领域:
- * 分子生物学 * 分子生物学
- * 癌症研究研究
- * 表观遗传学 是一种表观遗传学.
背景情况:
- *DOT1L和Menin对于MLL融合蛋白 (MLL-FP) 在白血病中的致癌活性至关重要.
- *DOT1L和Menin抑制剂疗效的确切机制尚未完全理解.
研究的目的:
- *阐明非正规的聚合物抑制复合体1.1 (PRC1.1) 在细胞对DOT1L和Menin抑制剂的反应中的作用.
- * 调查在MLL-FP驱动的白血病中DOT1L,Menin和PRC1.1之间的监管交叉声.
主要方法:
- *研究了Menin和DOT1L抑制对基因素修饰 (H2AK119ub,H3K79甲基化) 和PRC1.1活性的影响.
- *分析了MLL-FP向基因表达和PRC1.1活性,以应对抑制剂治疗.
- *研究了H3K79甲基化和PRC1活性之间的生化关系.
主要成果:
- * 脑膜抑制触发了依赖PRC1.1的H2AK119ub沉积,使特定的MLL-FP目标沉默.
- *DOT1L抑制导致H2AK119ub的全球增加,这是由于PRC1.1活动的增强.
- * 增强的PRC1.1活性来自DOT1L介导的H3K79甲基化损失,独立于MLL-FP位移.
- * 在H3K79甲基化和PRC1活性之间存在直接的生化对抗作用.
结论:
- *PRC1.1在调解白血病中对DOT1L和Menin抑制剂的细胞反应中发挥着关键作用.
- *DOT1L作为在白血病中被利用的转录记忆的组成部分.
- * 这项研究确定DOT1L是平衡白血病MLL-多轴的关键调节器.
更多相关视频
09:05Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)
Published on: June 12, 2017
10:43Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
Published on: July 1, 2014
相关概念视频
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Transcription Factors
Master Transcription Regulators
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...